(Q46199542)

20 December 2017

title

Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis (English)

1 reference

20 December 2017

0 references

1 reference

Flores-Aguilar M

1

1 reference

20 December 2017

Kuppermann BD

2

1 reference

20 December 2017

Quiceno JI

3

1 reference

20 December 2017

Dankner WM

4

1 reference

20 December 2017

Wolf DG

5

1 reference

20 December 2017

Capparelli EV

6

1 reference

20 December 2017

Connor JD

7

1 reference

20 December 2017

Sherwood CH

8

1 reference

20 December 2017

Fullerton S

9

1 reference

20 December 2017

Gambertoglio JG

10

1 reference

20 December 2017

publication date

1 July 1993

1 reference

20 December 2017

published in

Ophthalmology

1 reference

20 December 2017

volume

100

1 reference

20 December 2017

issue

7

1 reference

20 December 2017

page(s)

1022-1031

1 reference

20 December 2017

Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Isolation of Foscarnet-Resistant Human Cytomegalovirus Patterns of Resistance and Sensitivity to Other Antiviral Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Human pharmacokinetics of the antiviral drug DHPG.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931523-X

7 January 2021

10.1016/S0161-6420(93)31523-X

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017